IIPLA News
Thursday, July 23, 2026

US Government Alleges Chinese AI Firm Moonshot AI Illegally Used Anthropic’s Model to Develop K3

Washington considers trade sanctions against Moonshot AI amid escalating US-China AI technology tensions

IIPLA News Deskanonymous access0 articles left this week
US Government Alleges Chinese AI Firm Moonshot AI Illegally Used Anthropic’s Model to Develop K3

The United States government has formally accused Chinese artificial intelligence startup Moonshot AI of misappropriating Anthropic’s advanced large language model, Fable, to develop its recently launched K3 AI model. This development was disclosed by senior US officials, including Michael Kratsios, the White House’s chief technology officer, and Treasury Secretary Scott Bessent.

Kratsios stated on the social media platform X that the US possesses information indicating Moonshot AI engaged in "large-scale, covert industrial distillation" of Anthropic’s Fable model to create its K3 system. He emphasized that such unauthorized use of proprietary US technology undermines American research and is unacceptable.

In a separate post on X, Treasury Secretary Bessent announced that he is considering placing Moonshot AI on a US trade blacklist and imposing sanctions as a response to these allegations. These actions reflect growing concerns over intellectual property theft and technology transfer risks amid intensifying competition in AI development between the US and China.

The accusations come shortly after Moonshot AI unveiled Kimi K3, a 2.8 trillion-parameter open-weight AI model that the company claims approaches the performance of Anthropic’s Fable. This launch underscores the rapid advancement of China’s AI capabilities and its narrowing gap with leading US developers.

Anthropic has previously reported that three Chinese AI companies—DeepSeek, Moonshot AI, and MiniMax—violated its terms of service by using its Claude model to improve their own AI systems. According to Anthropic, these companies created over 16 million interactions through approximately 24,000 fake accounts, breaching regional access restrictions.

Model distillation, the process at the center of these allegations, involves training smaller AI models using outputs generated by larger, more capable models. This technique can reduce development costs but raises intellectual property concerns when done without authorization.

Further complicating the situation, Kratsios alleged that Moonshot AI acquired servers equipped with Nvidia’s GB300 AI chips and deployed them in Thailand, likely to train its AI models. This claim echoes earlier accusations from a senior Trump administration official that Chinese AI startup DeepSeek used Nvidia’s advanced AI chips in violation of US export controls.

The Chinese embassy in Washington has rejected the US allegations as "entirely unfounded." Embassy spokesperson Liu Chang stated that China respects intellectual property protections and urged US officials to "respect the facts, discard prejudice and stop smearing and discrediting China’s achievements in the development of its artificial intelligence industry."

Share This Article
Ready-to-post copy includes the article link.

US Government Alleges Chinese AI Firm Moonshot AI Illegally Used Anthropic’s Model to Develop K3 The US Treasury and White House officials have accused Chinese AI startup Moonshot AI of illicitly using Anthropic’s proprietary Fable large language model to create its own K3 model. The allegations include unauthorize... Read the full IIPLA article: https://iipla.org/news/us-government-alleges-chinese-ai-firm-moonshot-ai-illegally-used-anthropic-s-model-to-develop-k3

Related Coverage

Continue in the newsroom

Back to newsroom
PatentsGlobal

Paul Weiss Expands Life Sciences Practice with Partner Ian Edvalson in San Francisco

Paul, Weiss, Rifkind, Wharton & Garrison has appointed Ian Edvalson as a partner in its San Francisco office, strengthening the firm’s life sciences transactions and intellectual property practices. Edvalson brings extensive experience advising biopharmaceutical and medical technology companies on licensing, collabora…

Friday, August 7, 2026
PatentsGlobal

Mexican Patent Law Overhaul Demands Early Strategic Planning from Applicants

In the first half of 2026, Mexico implemented sweeping patent reforms that significantly alter how patent applications are prepared, filed, and prosecuted. Key changes include a reduction in the number of substantive office actions and a mandated one-year examination timeline, compelling applicants to adopt earlier an…

Friday, August 7, 2026
PatentsGlobal

China Advances Comprehensive Pharmaceutical IP Protection with New Regulatory Frameworks

China’s pharmaceutical sector is rapidly evolving from generic manufacturing to innovative drug development, supported by a robust intellectual property protection system. Key measures including regulatory data protection, patent term extensions, patent linkage mechanisms, and strengthened judicial and administrative…

Friday, August 7, 2026
PatentsGlobal

T&G Global Posts Strong First-Half Results Driven by Premium Apple Sales

T&G Global reported a 2.6% revenue increase to $572.3 million for the six months ending June 30, 2024, led by a 6.1% rise in its Apples division revenue to $550.9 million. Operating profit grew 30% to $11.6 million before impairment adjustments related to the sale of T&G Fresh businesses. The company highlighted signi…

Friday, August 7, 2026